dual estrogen receptor-alpha/NF-kappa-B inhibitors (Wuhan University School of Pharmaceutical Sciences/Xidian University/Wuhan University)

N/A

Report date: 2025/03/19 09:03:25
NME

Base Information

Drug Namedual estrogen receptor-alpha/NF-kappa-B inhibitors (Wuhan University School of Pharmaceutical Sciences/Xidian University/Wuhan University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsEstrogen receptor alpha degraders
TargetsNuclear factor NF-kappa-B complexEstrogen receptor alpha
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWuhan University School of Pharmaceutical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesXidian UniversityWuhan University School of Pharmaceutical SciencesWuhan University
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A